[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]
Identifieur interne : 000015 ( Main/Exploration ); précédent : 000014; suivant : 000016[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]
Auteurs : Nello Martini ; Carlo Piccinni ; Antonella Pedrini ; Aldo MaggioniSource :
- Recenti progressi in medicina [ 2038-1840 ] ; 2020.
Descripteurs français
- KwdFr :
- Anticoagulants (usage thérapeutique), Collecte de données, Comorbidité, Connaissances, attitudes et pratiques en santé, Facteurs de risque, Humains, Hypoglycémiants (usage thérapeutique), Infections à coronavirus (), Infections à coronavirus (épidémiologie), Maladie chronique, Maladies de l'appareil respiratoire, Pandémies, Planification des soins du patient, Pneumopathie virale (), Pneumopathie virale (épidémiologie), Populations vulnérables.
- MESH :
- usage thérapeutique : Anticoagulants, Hypoglycémiants.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Collecte de données, Comorbidité, Connaissances, attitudes et pratiques en santé, Facteurs de risque, Humains, Infections à coronavirus, Maladie chronique, Maladies de l'appareil respiratoire, Pandémies, Planification des soins du patient, Pneumopathie virale, Populations vulnérables.
English descriptors
- KwdEn :
- Anticoagulants (therapeutic use), Betacoronavirus, Chronic Disease, Comorbidity, Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Data Collection, Health Knowledge, Attitudes, Practice, Humans, Hypoglycemic Agents (therapeutic use), Pandemics, Patient Care Planning, Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Respiratory Tract Diseases, Risk Factors, Vulnerable Populations.
- MESH :
- chemical , therapeutic use : Anticoagulants, Hypoglycemic Agents.
- complications : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, Chronic Disease, Comorbidity, Data Collection, Health Knowledge, Attitudes, Practice, Humans, Pandemics, Patient Care Planning, Respiratory Tract Diseases, Risk Factors, Vulnerable Populations.
Abstract
Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease. Epidemiological data and studies performed show different rates of chronic diseases and multimorbidity among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has taken measures to extend the therapeutic plans and monitoring registers; hopefully, therapeutic plans for antidiabetics, drugs for respiratory diseases and oral anticoagulant drugs will be abolished since they do not offer any additional advantage in terms of appropriateness and traceability of outcomes. The MaCroScopio project (Observatory on Chronic Diseases), regarding the CoViD-19 emergency, has started a new research path to foster the integration of the administrative data flows with the CoViD-19 Registers for planning and research purposes in the context of chronicity, as well as to evaluate the economic and organizational impact of the pandemic.
DOI: 10.1701/3347.33180
PubMed: 32319439
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000046
- to stream PubMed, to step Curation: 000046
- to stream PubMed, to step Checkpoint: 000009
- to stream Ncbi, to step Merge: 000F64
- to stream Ncbi, to step Curation: 000F64
- to stream Ncbi, to step Checkpoint: 000F64
- to stream Main, to step Merge: 000015
- to stream Main, to step Curation: 000015
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]</title><author><name sortKey="Martini, Nello" sort="Martini, Nello" uniqKey="Martini N" first="Nello" last="Martini">Nello Martini</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Piccinni, Carlo" sort="Piccinni, Carlo" uniqKey="Piccinni C" first="Carlo" last="Piccinni">Carlo Piccinni</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Pedrini, Antonella" sort="Pedrini, Antonella" uniqKey="Pedrini A" first="Antonella" last="Pedrini">Antonella Pedrini</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Maggioni, Aldo" sort="Maggioni, Aldo" uniqKey="Maggioni A" first="Aldo" last="Maggioni">Aldo Maggioni</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32319439</idno><idno type="pmid">32319439</idno><idno type="doi">10.1701/3347.33180</idno><idno type="wicri:Area/PubMed/Corpus">000046</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000046</idno><idno type="wicri:Area/PubMed/Curation">000046</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000046</idno><idno type="wicri:Area/PubMed/Checkpoint">000009</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000009</idno><idno type="wicri:Area/Ncbi/Merge">000F64</idno><idno type="wicri:Area/Ncbi/Curation">000F64</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F64</idno><idno type="wicri:Area/Main/Merge">000015</idno><idno type="wicri:Area/Main/Curation">000015</idno><idno type="wicri:Area/Main/Exploration">000015</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]</title><author><name sortKey="Martini, Nello" sort="Martini, Nello" uniqKey="Martini N" first="Nello" last="Martini">Nello Martini</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Piccinni, Carlo" sort="Piccinni, Carlo" uniqKey="Piccinni C" first="Carlo" last="Piccinni">Carlo Piccinni</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Pedrini, Antonella" sort="Pedrini, Antonella" uniqKey="Pedrini A" first="Antonella" last="Pedrini">Antonella Pedrini</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author><author><name sortKey="Maggioni, Aldo" sort="Maggioni, Aldo" uniqKey="Maggioni A" first="Aldo" last="Maggioni">Aldo Maggioni</name><affiliation><nlm:affiliation>Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).</nlm:affiliation><wicri:noCountry code="subField">Casalecchio di Reno (Bologna)</wicri:noCountry></affiliation></author></analytic><series><title level="j">Recenti progressi in medicina</title><idno type="eISSN">2038-1840</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticoagulants (therapeutic use)</term><term>Betacoronavirus</term><term>Chronic Disease</term><term>Comorbidity</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (epidemiology)</term><term>Data Collection</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Hypoglycemic Agents (therapeutic use)</term><term>Pandemics</term><term>Patient Care Planning</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (epidemiology)</term><term>Respiratory Tract Diseases</term><term>Risk Factors</term><term>Vulnerable Populations</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticoagulants (usage thérapeutique)</term><term>Collecte de données</term><term>Comorbidité</term><term>Connaissances, attitudes et pratiques en santé</term><term>Facteurs de risque</term><term>Humains</term><term>Hypoglycémiants (usage thérapeutique)</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (épidémiologie)</term><term>Maladie chronique</term><term>Maladies de l'appareil respiratoire</term><term>Pandémies</term><term>Planification des soins du patient</term><term>Pneumopathie virale ()</term><term>Pneumopathie virale (épidémiologie)</term><term>Populations vulnérables</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term><term>Hypoglycemic Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term><term>Hypoglycémiants</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Chronic Disease</term><term>Comorbidity</term><term>Data Collection</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Pandemics</term><term>Patient Care Planning</term><term>Respiratory Tract Diseases</term><term>Risk Factors</term><term>Vulnerable Populations</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Collecte de données</term><term>Comorbidité</term><term>Connaissances, attitudes et pratiques en santé</term><term>Facteurs de risque</term><term>Humains</term><term>Infections à coronavirus</term><term>Maladie chronique</term><term>Maladies de l'appareil respiratoire</term><term>Pandémies</term><term>Planification des soins du patient</term><term>Pneumopathie virale</term><term>Populations vulnérables</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease. Epidemiological data and studies performed show different rates of chronic diseases and multimorbidity among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has taken measures to extend the therapeutic plans and monitoring registers; hopefully, therapeutic plans for antidiabetics, drugs for respiratory diseases and oral anticoagulant drugs will be abolished since they do not offer any additional advantage in terms of appropriateness and traceability of outcomes. The MaCroScopio project (Observatory on Chronic Diseases), regarding the CoViD-19 emergency, has started a new research path to foster the integration of the administrative data flows with the CoViD-19 Registers for planning and research purposes in the context of chronicity, as well as to evaluate the economic and organizational impact of the pandemic.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Maggioni, Aldo" sort="Maggioni, Aldo" uniqKey="Maggioni A" first="Aldo" last="Maggioni">Aldo Maggioni</name><name sortKey="Martini, Nello" sort="Martini, Nello" uniqKey="Martini N" first="Nello" last="Martini">Nello Martini</name><name sortKey="Pedrini, Antonella" sort="Pedrini, Antonella" uniqKey="Pedrini A" first="Antonella" last="Pedrini">Antonella Pedrini</name><name sortKey="Piccinni, Carlo" sort="Piccinni, Carlo" uniqKey="Piccinni C" first="Carlo" last="Piccinni">Carlo Piccinni</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000015 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000015 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32319439
|texte= [CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32319439" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |